Kroger Launches Zepbound® KwikPen Medication
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy KR?
Source: PRnewswire
- Increased Medication Accessibility: Kroger pharmacies now offer Eli Lilly's new multi-dose weight management medication, Zepbound® KwikPen, providing patients with a more convenient option for obtaining their medication, reflecting Kroger's ongoing commitment to expanding access to high-demand GLP-1 therapies.
- Self-Pay Patient Benefits: For the first time, self-pay patients can access Lilly's KwikPen Self-Pay Savings Card at retail pharmacies, helping eligible patients lower out-of-pocket costs, thereby enhancing Kroger's patient support services.
- Comprehensive Support Services: Kroger pharmacies provide a range of services for patients filling GLP-1 prescriptions, aimed at supporting adherence, education, and long-term health outcomes, which underscores Kroger's patient-centered mission.
- Community Health Commitment: Kroger is dedicated to meeting the needs of customers and communities by offering affordable and effective weight management treatment options, promoting health and well-being, and embodying its corporate purpose of 'Feeding the Human Spirit.'
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KR
Wall Street analysts forecast KR stock price to rise
15 Analyst Rating
9 Buy
6 Hold
0 Sell
Moderate Buy
Current: 74.960
Low
68.00
Averages
75.00
High
85.00
Current: 74.960
Low
68.00
Averages
75.00
High
85.00
About KR
The Kroger Co. is a food and drug retailer. The Company operates supermarkets, multi-department stores and fulfillment centers throughout the United States. It operates approximately 2,731 supermarkets, 2,273 pharmacies and 1,702 fuel centers in over 35 states and the District of Columbia while also operating online through a digital ecosystem to offer customers an omnichannel shopping experience. The Company also manufactures and processes food for sale in its supermarkets and online. It offers Pickup and Harris Teeter ExpressLane personalized, order online, pick-up at the store services at approximately 2,412 of its supermarkets and provides delivery, which allows it to offer digital solutions to substantially all of its customers. Its delivery solutions include orders delivered to customers at retail store locations, customer fulfillment centers and orders placed through third-party platforms. The Company also offers customer-facing apps and interfaces.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Kroger Launches Zepbound® KwikPen for Weight Management
- Increased Accessibility: Kroger pharmacies now offer Eli Lilly's new multi-dose weight management medication, Zepbound® KwikPen, marking the first time self-pay patients can access the manufacturer's savings program, significantly reducing out-of-pocket costs and enhancing medication accessibility and convenience.
- Patient Support Services: Kroger pharmacies provide personalized pharmacist counseling, virtual nutrition care, and integrated care with The Little Clinic for patients filling GLP-1 prescriptions, ensuring comprehensive support throughout the health management journey, which improves patient adherence and long-term health outcomes.
- Nutrition and Health Integration: Patients can fill their prescriptions while accessing a variety of fresh, protein- and fiber-rich foods at Kroger, showcasing the unique advantage of combining pharmacy services with nutritional support, thereby promoting overall patient health.
- Community Commitment: Kroger is dedicated to meeting the needs of customers and communities by providing affordable and effective weight management treatment options, reflecting its patient-centered mission to enhance health experiences through pharmacy services.
See More
Kroger Launches Zepbound® KwikPen Medication
- Increased Medication Accessibility: Kroger pharmacies now offer Eli Lilly's new multi-dose weight management medication, Zepbound® KwikPen, providing patients with a more convenient option for obtaining their medication, reflecting Kroger's ongoing commitment to expanding access to high-demand GLP-1 therapies.
- Self-Pay Patient Benefits: For the first time, self-pay patients can access Lilly's KwikPen Self-Pay Savings Card at retail pharmacies, helping eligible patients lower out-of-pocket costs, thereby enhancing Kroger's patient support services.
- Comprehensive Support Services: Kroger pharmacies provide a range of services for patients filling GLP-1 prescriptions, aimed at supporting adherence, education, and long-term health outcomes, which underscores Kroger's patient-centered mission.
- Community Health Commitment: Kroger is dedicated to meeting the needs of customers and communities by offering affordable and effective weight management treatment options, promoting health and well-being, and embodying its corporate purpose of 'Feeding the Human Spirit.'
See More
Kroger Introduces Zepbound® KwikPen in Retail Pharmacies, Enhancing Access and Cost Savings for Self-Paying Patients
Expansion of Services: KROGER BRINGS ZEPBOUND® KWIKPEN to retail pharmacy, enhancing access for self-pay patients.
Focus on Savings: The initiative aims to provide savings opportunities for patients who pay out-of-pocket for their medications.
See More
Surge in Oil Prices and Upcoming Economic Data Release
- Oil Price Surge: Brent crude futures have risen 40% since the war began, while West Texas Intermediate has increased by 45%, which could have profound implications for the global economy, particularly amid rising inflationary pressures.
- Economic Data Release: The Personal Consumption Expenditures (PCE) price index is set to be released at 8:30 a.m. ET, with expectations of a 0.3% month-over-month increase and a 2.9% year-over-year rise, providing crucial inflation signals that will influence investor decisions.
- Food Stock Performance: Kroger's stock has gained 10% since the war started and is up about 20% in 2026, demonstrating the resilience and growth potential of food retailers in an uncertain market environment.
- Energy Company Highs: Several energy companies, including Marathon Petroleum and Phillips 66, have reached all-time highs, with increases of 16% and 13% respectively, reflecting strong market expectations for energy demand and a recovering investor confidence in the sector.
See More
PepsiCo and JetBlue Upgraded Amid Strengthening Fundamentals
- PepsiCo Upgrade: Bay Area Ideas upgraded PepsiCo from Hold to Buy as tariff pressures ease, with organic revenue growth and margins accelerating, positioning the company for strong growth in the coming years.
- JetBlue Rating Adjustment: Analyst Albert Anthony raised JetBlue's rating to Hold, driven by new routes in Florida and Texas and progress in reducing operational costs, although high debt levels remain a concern for the airline's future.
- Kroger Downgrade: IWA Research downgraded Kroger from Buy to Hold after a 15% stock price recovery, believing the current valuation reflects most potential upside, with free cash flow expected to normalize by 2026.
- NIO Caution: Despite achieving its first GAAP quarterly profit, NIO faces skepticism regarding its growth targets due to weak early 2026 delivery numbers and rising input costs, putting pressure on management's aggressive guidance for 40% to 50% year-over-year volume growth.
See More
Kroger Named Among Best American Dividend Stocks
- Price Target Increase: Evercore ISI analyst raised Kroger's price target from $81 to $83, reiterating an Outperform rating, indicating strong market confidence in the company's future performance.
- Sales Growth Forecast: Kroger projects comparable sales growth of 1% to 2% for 2026, falling short of the market's expectation of 2%, reflecting challenges in a competitive retail environment.
- New Strategic Initiatives: New CEO Greg Foran aims to expand market share by focusing on more affordable fresh food and responsive delivery services to attract budget-conscious consumers, thereby driving traffic and basket growth.
- Earnings Projections: Kroger anticipates adjusted earnings per share between $5.10 and $5.30, slightly below the market expectation of $5.29, indicating some pressure on the company's profitability.
See More
Kroger Launches Zepbound® KwikPen for Weight Management
- Increased Accessibility: Kroger pharmacies now offer Eli Lilly's new multi-dose weight management medication, Zepbound® KwikPen, marking the first time self-pay patients can access the manufacturer's savings program, significantly reducing out-of-pocket costs and enhancing medication accessibility and convenience.
- Patient Support Services: Kroger pharmacies provide personalized pharmacist counseling, virtual nutrition care, and integrated care with The Little Clinic for patients filling GLP-1 prescriptions, ensuring comprehensive support throughout the health management journey, which improves patient adherence and long-term health outcomes.
- Nutrition and Health Integration: Patients can fill their prescriptions while accessing a variety of fresh, protein- and fiber-rich foods at Kroger, showcasing the unique advantage of combining pharmacy services with nutritional support, thereby promoting overall patient health.
- Community Commitment: Kroger is dedicated to meeting the needs of customers and communities by providing affordable and effective weight management treatment options, reflecting its patient-centered mission to enhance health experiences through pharmacy services.
See More
Kroger Launches Zepbound® KwikPen Medication
- Increased Medication Accessibility: Kroger pharmacies now offer Eli Lilly's new multi-dose weight management medication, Zepbound® KwikPen, providing patients with a more convenient option for obtaining their medication, reflecting Kroger's ongoing commitment to expanding access to high-demand GLP-1 therapies.
- Self-Pay Patient Benefits: For the first time, self-pay patients can access Lilly's KwikPen Self-Pay Savings Card at retail pharmacies, helping eligible patients lower out-of-pocket costs, thereby enhancing Kroger's patient support services.
- Comprehensive Support Services: Kroger pharmacies provide a range of services for patients filling GLP-1 prescriptions, aimed at supporting adherence, education, and long-term health outcomes, which underscores Kroger's patient-centered mission.
- Community Health Commitment: Kroger is dedicated to meeting the needs of customers and communities by offering affordable and effective weight management treatment options, promoting health and well-being, and embodying its corporate purpose of 'Feeding the Human Spirit.'
See More
Kroger Introduces Zepbound® KwikPen in Retail Pharmacies, Enhancing Access and Cost Savings for Self-Paying Patients
Expansion of Services: KROGER BRINGS ZEPBOUND® KWIKPEN to retail pharmacy, enhancing access for self-pay patients.
Focus on Savings: The initiative aims to provide savings opportunities for patients who pay out-of-pocket for their medications.
See More
Surge in Oil Prices and Upcoming Economic Data Release
- Oil Price Surge: Brent crude futures have risen 40% since the war began, while West Texas Intermediate has increased by 45%, which could have profound implications for the global economy, particularly amid rising inflationary pressures.
- Economic Data Release: The Personal Consumption Expenditures (PCE) price index is set to be released at 8:30 a.m. ET, with expectations of a 0.3% month-over-month increase and a 2.9% year-over-year rise, providing crucial inflation signals that will influence investor decisions.
- Food Stock Performance: Kroger's stock has gained 10% since the war started and is up about 20% in 2026, demonstrating the resilience and growth potential of food retailers in an uncertain market environment.
- Energy Company Highs: Several energy companies, including Marathon Petroleum and Phillips 66, have reached all-time highs, with increases of 16% and 13% respectively, reflecting strong market expectations for energy demand and a recovering investor confidence in the sector.
See More
PepsiCo and JetBlue Upgraded Amid Strengthening Fundamentals
- PepsiCo Upgrade: Bay Area Ideas upgraded PepsiCo from Hold to Buy as tariff pressures ease, with organic revenue growth and margins accelerating, positioning the company for strong growth in the coming years.
- JetBlue Rating Adjustment: Analyst Albert Anthony raised JetBlue's rating to Hold, driven by new routes in Florida and Texas and progress in reducing operational costs, although high debt levels remain a concern for the airline's future.
- Kroger Downgrade: IWA Research downgraded Kroger from Buy to Hold after a 15% stock price recovery, believing the current valuation reflects most potential upside, with free cash flow expected to normalize by 2026.
- NIO Caution: Despite achieving its first GAAP quarterly profit, NIO faces skepticism regarding its growth targets due to weak early 2026 delivery numbers and rising input costs, putting pressure on management's aggressive guidance for 40% to 50% year-over-year volume growth.
See More
Kroger Named Among Best American Dividend Stocks
- Price Target Increase: Evercore ISI analyst raised Kroger's price target from $81 to $83, reiterating an Outperform rating, indicating strong market confidence in the company's future performance.
- Sales Growth Forecast: Kroger projects comparable sales growth of 1% to 2% for 2026, falling short of the market's expectation of 2%, reflecting challenges in a competitive retail environment.
- New Strategic Initiatives: New CEO Greg Foran aims to expand market share by focusing on more affordable fresh food and responsive delivery services to attract budget-conscious consumers, thereby driving traffic and basket growth.
- Earnings Projections: Kroger anticipates adjusted earnings per share between $5.10 and $5.30, slightly below the market expectation of $5.29, indicating some pressure on the company's profitability.
See More
